Related Experiment Videos
Structure-activity relationships of ring C-secotaxoids. 1. Acylative modifications
Giovanni Appendino1, Piergiorgio Bettoni, Alain Noncovich
1Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche, Università del Piemonte Orientale, Viale Ferrucci 33, 28100 Novara, Italy.
Journal of Natural Products
|February 28, 2004
Summary
Acylating IDN 5390, a preclinical 7,8-secotaxoid, slightly reduced its potency. This suggests upper hydroxyl groups are not essential for cytotoxicity, differing from paclitaxel.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Pharmacology
Background:
- IDN 5390 is a 7,8-secotaxoid derivative undergoing preclinical evaluation.
- Understanding structure-activity relationships is crucial for drug development.
Purpose of the Study:
- To investigate the impact of acylative modification on the biological activity of IDN 5390.
- To determine the role of specific hydroxyl groups in the cytotoxicity of IDN 5390.
Main Methods:
- Synthesis of acylated analogues of IDN 5390.
- Evaluation of the cytotoxic potency of the parent compound and its derivatives.
Main Results:
- Acylation of primary and enolic hydroxyls resulted in a modest decrease in potency.
- The hydroxyl groups in the upper right-hand sector are not critical for cytotoxicity.
- Chemically stable carbonate analogues (3c and 3d) retained significant activity.
Conclusions:
- The cytotoxicity of IDN 5390 is unlikely to be mediated by in vivo oxidation to a 7-aldehyde followed by re-aldolization.
- The findings suggest a distinct mechanism of action or structural requirement for IDN 5390 compared to paclitaxel.